Cargando…
Neuromodulation in Inflammatory Skin Disease
Inflammatory skin diseases are difficult to treat because of a lack of available treatment options for severe disease. However, recent advances have shown that vagus nerve stimulation can be used to decrease inflammation and reduce disease severity in rheumatoid arthritis and inflammatory bowel dise...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5825332/ https://www.ncbi.nlm.nih.gov/pubmed/29427206 http://dx.doi.org/10.1007/s13555-018-0227-4 |
_version_ | 1783302174018633728 |
---|---|
author | Yang, Eric J. Sekhon, Sahil Beck, Kristen M. Bhutani, Tina Koo, John |
author_facet | Yang, Eric J. Sekhon, Sahil Beck, Kristen M. Bhutani, Tina Koo, John |
author_sort | Yang, Eric J. |
collection | PubMed |
description | Inflammatory skin diseases are difficult to treat because of a lack of available treatment options for severe disease. However, recent advances have shown that vagus nerve stimulation can be used to decrease inflammation and reduce disease severity in rheumatoid arthritis and inflammatory bowel disease. Changes in cytokine profiles observed in these studies are similar to those seen with use of biologics in inflammatory skin disease, suggesting that they act along similar pathways to disrupt chronic inflammation and treat inflammatory disease. This commentary explores the existing evidence demonstrating the efficacy of neuromodulation in inflammatory disease, and outlines reasons why these findings could translate to the dermatology setting to treat inflammatory skin disease. |
format | Online Article Text |
id | pubmed-5825332 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Springer Healthcare |
record_format | MEDLINE/PubMed |
spelling | pubmed-58253322018-02-28 Neuromodulation in Inflammatory Skin Disease Yang, Eric J. Sekhon, Sahil Beck, Kristen M. Bhutani, Tina Koo, John Dermatol Ther (Heidelb) Commentary Inflammatory skin diseases are difficult to treat because of a lack of available treatment options for severe disease. However, recent advances have shown that vagus nerve stimulation can be used to decrease inflammation and reduce disease severity in rheumatoid arthritis and inflammatory bowel disease. Changes in cytokine profiles observed in these studies are similar to those seen with use of biologics in inflammatory skin disease, suggesting that they act along similar pathways to disrupt chronic inflammation and treat inflammatory disease. This commentary explores the existing evidence demonstrating the efficacy of neuromodulation in inflammatory disease, and outlines reasons why these findings could translate to the dermatology setting to treat inflammatory skin disease. Springer Healthcare 2018-02-09 /pmc/articles/PMC5825332/ /pubmed/29427206 http://dx.doi.org/10.1007/s13555-018-0227-4 Text en © The Author(s) 2018 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Commentary Yang, Eric J. Sekhon, Sahil Beck, Kristen M. Bhutani, Tina Koo, John Neuromodulation in Inflammatory Skin Disease |
title | Neuromodulation in Inflammatory Skin Disease |
title_full | Neuromodulation in Inflammatory Skin Disease |
title_fullStr | Neuromodulation in Inflammatory Skin Disease |
title_full_unstemmed | Neuromodulation in Inflammatory Skin Disease |
title_short | Neuromodulation in Inflammatory Skin Disease |
title_sort | neuromodulation in inflammatory skin disease |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5825332/ https://www.ncbi.nlm.nih.gov/pubmed/29427206 http://dx.doi.org/10.1007/s13555-018-0227-4 |
work_keys_str_mv | AT yangericj neuromodulationininflammatoryskindisease AT sekhonsahil neuromodulationininflammatoryskindisease AT beckkristenm neuromodulationininflammatoryskindisease AT bhutanitina neuromodulationininflammatoryskindisease AT koojohn neuromodulationininflammatoryskindisease |